drugset
drugset / Trial / NCT02006576

Prostaglandin Inhibition for Emphysema

NCT02006576 ↗

Phase 2 Completed 118 enrolled University of Nebraska National Jewish Health · collabTemple University · collabUniversity of Alabama at Birmingham · collabUniversity of California, Los Angeles · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Prostaglandin Inhibition for Emphysema (PIE) study will determine if a currently available therapy, ibuprofen 600 mg three times daily, can block PGE production in the lower respiratory tract and if this results in improvement in measures of lung repair function.

Timeline

Start
2014-01-01
Primary completion
2018-03-31
Completion
2018-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 600 mg —

Indications

pulmonary emphysema